华泰证券股份有限公司研究员代雯、袁中平、李航1月13日发布研报《荣昌生物(688331)：RC148重磅 BD启动全球拓展》称，维持6.5%的WACC，2.5%的永续增长率，调整基于DCF的A股的目标价为151.79 元(前值：140.42元)，并调整A/H溢价为16.46%(与过去3个月荣昌生物A/H溢价一致，前值：8.95%)，调 整H股目标价为142.72港币(前值：141.13港币)，维持A股和H股"买入"评级。 华安证券（600909）股份有限公司研究员谭国超、任婉莹1月13日发布研报《荣昌生物(688331)：RC148 授权艾伯维进入大药POSTBD阶段》称，看好RC148后续的临床推进、公司后续管线的推进、公司上市 产品的销售稳定放量，维持"买入"评级。 中国经济网北京1月14日讯荣昌生物(688331.SH)今日收报103.34元，跌幅9.72%。 ...

蛋壳是鸡蛋的"天然屏障"，其状态直接反映新鲜度与安全性。 表面粗糙有白霜：新鲜鸡蛋的蛋壳覆盖一层白色霜状物，这是天然保护膜，能阻挡细菌侵入、减少 水分流失。若蛋壳光滑发亮、无白霜，说明存放时间较长，新鲜度下降。 无裂纹与污渍：蛋壳出现裂纹或附着污物时，细菌易侵入导致变质或沙门氏菌污染。即使清洗后， 保护膜被破坏，反而加速变质。 颜色与品种无关：红壳、白壳或粉壳鸡蛋的营养成分差异极小，蛋壳颜色仅由鸡的品种决定，无需 盲目追求特定颜色。 鸡蛋是日常饮食中的"营养全能选手"，但市场上的品类繁多，价格差异大，消费者常陷入选择困 境。其实，挑选高品质鸡蛋无需复杂技巧，只需抓住蛋壳状态、新鲜度验证、安全性标准这3个核心指 标，就能避开营销陷阱，选到真正营养又安全的好蛋。 蛋壳状态：天然保护层的"第一道防线" 在灯光或手电筒下观察鸡蛋，新鲜鸡蛋的蛋黄轮廓清晰、位于中心，气室(蛋壳顶端的小空腔)直径 不超过5毫米；若气室明显扩大、蛋黄偏离中心或出现黑影，则可能变质。 打开观察(备用方法)： 若需进一步验证，可打开鸡蛋：新鲜鸡蛋的蛋黄饱满圆润、呈金黄色，蛋白浓稠分层；若蛋黄扁 平、颜色暗淡，蛋白稀薄如水，则已不新鲜。 安全性标 ...

Market Overview - The A-share market experienced a decline in the afternoon session, with the Shanghai Composite Index falling by 0.31% to close at 4126.09 points, while the Shenzhen Component Index rose by 0.56% to 14248.60 points, and the ChiNext Index increased by 0.82% to 3349.14 points [1] Sector Performance - The leading sectors in terms of gains included: - Internet E-commerce, which rose by 5.69% with a total transaction volume of 1,059.10 million hands and a transaction value of 140.18 billion [2] - IT Services, increasing by 4.09% with a transaction volume of 10,004.50 million hands and a transaction value of 1,902.82 billion [2] - Cultural Media, up by 3.98% with a transaction volume of 9,470.94 million hands and a transaction value of 1,498.68 billion [2] - The sectors that experienced declines included: - Insurance, which fell by 2.00% with a transaction volume of 371.77 million hands and a transaction value of 166.07 billion [2] - Banking, down by 1.45% with a transaction volume of 5,198.16 million hands and a transaction value of 426.83 billion [2] - Airport and Shipping, decreasing by 1.12% with a transaction volume of 1,481.87 million hands and a transaction value of 87.71 billion [2]

Core Viewpoint - The lawsuit initiated by Weirui against XWANDA highlights significant quality issues with battery cells supplied to Weirui, leading to a claim of 2.314 billion yuan, which has drawn considerable attention to the dynamics between automakers and their suppliers in the rapidly evolving electric vehicle market [1][19][27]. Group 1: Company Developments - XWANDA's subsidiary, XWANDA Power, is being sued by Weirui Electric Vehicle Technology for quality issues related to battery cells delivered from June 2021 to December 2023, with a compensation claim of 2.314 billion yuan [1]. - Weirui, now part of Geely Holding Group's battery division, has undergone significant structural changes, including the formation of a new battery industry group aimed at achieving a production capacity of 70 GWh by 2027 [1][2]. - The merger of Weirui and Yao Ning into a battery industry group marks a strategic move for Geely to enhance its self-supply capabilities in the competitive electric vehicle market [2][21]. Group 2: Industry Context - The electric vehicle sector is witnessing intense competition, with companies like BYD and CATL leading the charge, prompting Geely to recognize the necessity of developing in-house battery production capabilities [2][29]. - The lawsuit against XWANDA not only targets quality issues but also reflects the internal power struggles within Geely, as the company navigates its supply chain and competitive positioning in the battery market [2][27]. - The restructuring within Geely's management and the establishment of the battery industry group signify a strategic pivot towards controlling more of the supply chain, particularly in battery production, which constitutes a significant portion of electric vehicle costs [29][30]. Group 3: Key Individuals - Xu Xiaoming, the founder of Jiangxi Anch, faced significant challenges after the acquisition by Geely, leading to his marginalization within the company and subsequent legal troubles related to alleged embezzlement [9][10][12]. - The leadership changes within Geely, particularly the roles of Zheng Xin and An Conghui, indicate a shift in focus towards integrating battery production with vehicle manufacturing, enhancing Geely's competitive edge [20][22][28]. - An Conghui's strategic decisions are pivotal in shaping Geely's approach to the battery market, as he aims to leverage the company's position to negotiate better terms with suppliers and expand into new markets [28][30].

(责任编辑：张海蛟) 中国经济网北京1月14日讯 今日，上海期货交易所日间盘黄金期货主力合约震荡收高，成交放大，持仓 减少。主力2602合约收报1040.62元，涨1.07%或11.04元;成交量为200947手;持仓为100662手，持仓减少 2971手。 隔夜，COMEX黄金期货跌0.43%，报4595美元/盎司。 ...

中国经济网北京1月14日讯 今日，上海国际能源交易中心日间盘原油期货主力合约震荡收高，成交放 大，持仓减少。主力2602合约收报445.5元，涨1.78%或7.8元;成交量为93761手;持仓为19989手，日盘持 仓减少2589手。 (责任编辑：张海蛟) 隔夜，纽约商品交易所2月交货的轻质原油期货价格上涨1.65美元，收于每桶61.15美元，涨幅为 2.77%。 ...

在资源循环利用方面，建立中药药渣资源化利用体系和包装材料回收机制，推动废弃物减量化、资源化，构建覆盖生产全链条的循环经济体系。 近日，江西省生态环境厅、省农业农村厅、省工业和信息化厅、省教育厅等四部门联合公布全省第二批"美丽细胞"建设优秀案例名单，仁和863科 技园凭借系统化的绿色发展实践和显著的生态建设成效，成功获评"美丽工厂"类优秀案例。这一荣誉标志着仁和集团在推进绿色制造、建设生态 友好型工业园区方面取得的成果获得省级权威认定，为区域工业绿色低碳发展提供了示范样本。 仁和863科技园作为仁和集团的核心生产园区，坐落于"中国药都"樟树市，占地千余亩。园区规划融合传统葫芦造型与现代功能布局，集研发制 造、智慧物流、生态景观于一体，多年来持续践行"绿色工厂"理念。园区以生态文明建设为引领，通过科学规划、节能降碳、循环利用、智能管 理和文化融入五大路径，系统构建了布局集约、生产清洁、环境友好、运营高效的发展模式。 在生态建设方面，园区坚持人与自然和谐共生，通过整体景观设计与生态修复，绿化覆盖率达到较高水平，形成"厂在林中、林在厂中"的花园式 格局。园区注重水资源循环利用，建立雨水收集系统和工艺冷凝水回收装置，年 ...

Core Viewpoint - The actual controller of Zhejiang Yongqiang, Xie Jianqiang, plans to reduce his shareholding in the company, which may impact investor sentiment but will not affect the company's control or governance structure [1][2]. Group 1: Shareholding Reduction Plan - Xie Jianqiang holds 97,613,130 shares, representing 4.50% of the total share capital, and plans to reduce his holdings by up to 24,403,282 shares, or 1.13% of the total share capital, within three months after the announcement [1]. - The reduction will be executed through centralized bidding and/or block trading methods [1]. Group 2: Financial Implications - Based on the closing price of 3.90 yuan on January 13, the estimated cash amount from the reduction is approximately 95.17 million yuan [2]. - Xie Jianqiang has cumulatively reduced his holdings by 41,031,500 shares since July 11, 2014, resulting in total cash proceeds of about 210 million yuan [2]. Group 3: Shareholding Structure - As of the announcement date, the controlling shareholder and actual controllers, including Xie Jianqiang and others, collectively hold 1.167 billion shares, accounting for 53.82% of the total share capital [2]. - The company asserts that the planned reduction will not lead to any changes in control or affect its governance structure and ongoing operations [2].

公告显示，安阳启旭、河南翔宇健康产业管理有限公司同受公司实际控制人何永正、郭军玲夫妇控 制。 翔宇医疗于2021年3月31日在上交所科创板上市，发行数量为40,000,000股（全部为新股，不安排老 股转让），发行价格为28.82元/股，保荐机构为海通证券股份有限公司（现更名为国泰海通证券股份有 限公司），保荐代表人为刘君、岑平一。 翔宇医疗首次公开发行募集资金总额115,280.00万元；扣除发行费用后，募集资金净额为104,965.66 万元。翔宇医疗最终募集资金净额较原计划多34,165.66万元。翔宇医疗于2021年3月25日发布的招股说 明书显示，公司拟募集资金70,800.00万元，智能康复医疗设备生产技术改造项目、养老及产后康复医疗 设备生产建设项目、康复设备研发及展览中心建设项目、智能康复设备（西南）研销中心项目、运营储 备资金。 翔宇医疗发行费用总额10,314.34万元，其中保荐及承销费用7,939.04万元。 中国经济网北京1月14日讯 翔宇医疗(688626.SH)昨日晚间披露关于股东减持股份计划公告。 公司股东安阳启旭贸易咨询服务中心（有限合伙）（简称"安阳启旭"）持有公司股份 8, ...

Core Viewpoint - The controlling shareholder and actual controller of Hongqiang Co., Ltd. plans to reduce their shareholding, which will not affect the company's control or governance structure significantly [1]. Group 1: Shareholding Reduction - The controlling shareholder, Liu Lianjun, holds 92,812,375 shares, accounting for 43.86% of the total share capital, and plans to reduce up to 2,116,100 shares, representing no more than 1.00% of the total share capital, within three months starting from February 5, 2026 [1]. - The estimated cash amount from this reduction, based on the closing price of 10.86 yuan per share, is approximately 22.98 million yuan [2]. Group 2: Previous Shareholding History - Liu Lianjun initially held 57,433,100 shares, which was 47.86% of the total share capital, and has cumulatively reduced 3,933,200 shares since September 19, 2019, realizing approximately 52.71 million yuan [2]. Group 3: Fundraising Activities - In 2023, Hongqiang Co., Ltd. issued convertible bonds to unspecified investors, raising a total of 316 million yuan, with a net amount of approximately 310.86 million yuan after deducting various fees [3]. - The issuance was approved by the China Securities Regulatory Commission on August 25, 2023, and the funds were received on October 24, 2023 [3].